Read the following passage about GLP-1 Therapies: A Global Health Initiative and mark the letter A, B, C or D on your answer sheet to indica...
Đề bài
Read the following passage about GLP-1 Therapies: A Global Health Initiative and mark the letter A, B, C or D on your answer sheet to indicate the option that best fits each of the numbered blanks from 18 to 22.
The World Health Organization has recently recommended GLP-1 therapies for obesity treatment in many countries around the world. These medicines, which include semaglutide and tirzepatide, (18)_________. If governments had taken decisive action earlier on obesity prevention programs, the expected cost of three trillion dollars per year by 2030 would have been avoided completely. Obesity is now recognized as a chronic disease requiring professional medical supervision, not just a lifestyle problem or personal choice.
(19)_________. The fact that fewer than ten percent of people who need these medicines will have them by 2030 shows serious and ongoing problems throughout the healthcare system. (20)_________. Most developing countries and poor communities cannot afford these expensive treatments for their citizens at all.
The WHO warns about serious manufacturing challenges and bottlenecks; furthermore, health systems in poor countries face many severe difficulties and resource shortages. These systemic factors prevent more people from receiving GLP-1 therapies effectively. Some GLP-1 drugs have been successfully added to the essential medicines list for diabetes treatment, (21)_________. The organization plans to work cooperatively with governments and international partners from 2026 onwards to improve access and lower prices significantly.
If countries invest in better production facilities and comprehensive support programs, more people could benefit from these important treatments. (22)_________, private businesses, and health organizations worldwide. Without immediate action and commitment, obesity will continue to cost the world billions of dollars annually and cause serious health problems for millions of vulnerable people everywhere.
https://www.reuters.com/tc
Question 18:
A. have been used to manage chronic diseases in people with obesity-related issues
B. serve for extended treatment among obese adults having significant metabolic conditions
C. are used for long-term care in adults with obesity and related health conditions
D. are provided during long-term management of patients with obesity complications
